ResMed Inc. (RMD)
After hours:
| Previous close | 215.82 |
| Open | 215.24 |
| Bid | 139.48 x 800 |
| Ask | 0.00 x 800 |
| Day's range | 212.50 - 216.54 |
| 52-week range | 189.40 - 253.67 |
| Volume | |
| Avg. volume | 650,696 |
| Market cap | 31.305B |
| Beta (5Y monthly) | 0.47 |
| PE ratio (TTM) | 38.89 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 1.76 (0.82%) |
| Ex-dividend date | 08 Feb 2023 |
| 1y target est | N/A |
- GlobeNewswire
ResMed Announces Participation in the 2023 KeyBanc Life Sciences & MedTech Investor Forum
SAN DIEGO, March 15, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will join a fireside chat at the 2023 KeyBanc Life Sciences & MedTech Investor Forum on Tuesday, March 21, 2023, beginning at approximately 3:45 p.m. (Eastern Daylight Time) via webcast. More information about this event, including access to the live, audio-only webcast, may be accessed by visiting https://investor.resmed.com. The audio-only webcast repla
- GlobeNewswire
ResMed’s Annual Global Sleep Survey Finds 8 in 10 Adults Experience Signs of Disruption Related to Their Quality of Sleep
81% of respondents experience one or more symptoms indicating poor sleep quality, despite 64% saying they’re satisfied with the quantity of their sleepWomen and older generations are less satisfied with the quality and quantity of their sleep compared to the survey’s overall average Annual survey aims to raise awareness for sleep health during National Sleep Awareness Week and World Sleep Day SAN DIEGO, March 13, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) announced today the results f
- GlobeNewswire
ResMed Announces Participation in the Oppenheimer 33rd Annual Healthcare Conference
SAN DIEGO, March 07, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will present at the Oppenheimer 33rd Annual Healthcare Conference on Monday, March 13, 2023, beginning at approximately 11:20 a.m. (Eastern Daylight Time) via webcast. More information about this event, including access to the live, audio-only webcast, may be accessed by visiting https://investor.resmed.com. The audio-only webcast replay will be available
